CLINICAL_TRIALS
withdrawal
· 2014-01-07
Clinical Trial Update: Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis [Phase 3]
Summary
A Phase 3 clinical trial evaluating tranexamic acid for preventing recurrence of hemoptysis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Hemoptysis | Phase 3 | Status: WITHDRAWN